Silvia Pieralice
YOU?
Author Swipe
View article: The Emerging Role of Anti-Hyperglycemic Agents for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
The Emerging Role of Anti-Hyperglycemic Agents for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease Open
The prevalence of type 2 diabetes mellitus (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly increasing worldwide. MASLD, previously known as non-alcoholic fatty liver disease (NAFLD), is defined as a co…
View article: L’eterogeneità del meccanismo autoimmune che conduce al diabete tipo 1 giustifica il fallimento dell’immunoterapia?
L’eterogeneità del meccanismo autoimmune che conduce al diabete tipo 1 giustifica il fallimento dell’immunoterapia? Open
Sommario Nonostante l’impegno profuso dai ricercatori negli ultimi 30 anni, ad oggi nessuno studio di immuno-intervento è riuscito a indurre la remissione del diabete tipo 1 (DM1) dopo l’insorgenza clinica. Una possibile causa risiede nell…
View article: Updates on Glycaemic Control Strategies: A Range of Opportunities after Total Pancreatectomy
Updates on Glycaemic Control Strategies: A Range of Opportunities after Total Pancreatectomy Open
In the past, indications for total pancreatectomy (TP) were rare, with several concerns about patients’ postoperative quality of life due to exocrine and endocrine post-pancreatectomy management [...]
View article: Prevaccination Glucose Time in Range Correlates With Antibody Response to SARS-CoV-2 Vaccine in Type 1 Diabetes
Prevaccination Glucose Time in Range Correlates With Antibody Response to SARS-CoV-2 Vaccine in Type 1 Diabetes Open
Context Poor glucose control has been associated with increased mortality in COVID-19 patients with type 1 diabetes (T1D). Objective This work aimed to assess the effect of prevaccination glucose control on antibody response to the SARS-Co…
View article: Layered Meta-Learning Algorithm for Predicting Adverse Events in Type 1 Diabetes
Layered Meta-Learning Algorithm for Predicting Adverse Events in Type 1 Diabetes Open
Type 1 diabetes mellitus (T1D) is a chronic disease that, if not treated properly, can lead to serious complications. We propose a layered meta-learning approach based on multi-expert systems to predict adverse events in T1D. The base lear…
View article: 769 EFFECT OF GLUCOSE LOWERING AGENTS ON CARDIAC AUTONOMIC FUNCTION AND STRUCTURE IN TYPE 2 DIABETES MELLITUS
769 EFFECT OF GLUCOSE LOWERING AGENTS ON CARDIAC AUTONOMIC FUNCTION AND STRUCTURE IN TYPE 2 DIABETES MELLITUS Open
Effects of novel glucose-lowering agents on cardiac autonomic function and structure in type 2 diabetes Ilaria Cavallari, Ernesto Maddaloni, Francesco Veneziano, Carla Indennidate, Maria Valeria Giaccari, Dario Tuccinardi, Silvia Pieralice…
View article: A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes
A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes Open
View article: Third dose of COVID‐19 vaccine in diabetes: Relevance of good metabolic control to improve its efficacy
Third dose of COVID‐19 vaccine in diabetes: Relevance of good metabolic control to improve its efficacy Open
Coronavirus (COVID‐19) disease is usually characterised by poorprognosis in patients with diabetes implying that mitigation of the COVID‐19 pandemic risk becomes a priority in patients with type 1 (T1D) or type 2 (T2D) diabetes.1 Despite t…
View article: Review for "Fasting C‐peptide at type 2 diabetes diagnosis is an independent risk factor for total and cancer mortality"
Review for "Fasting C‐peptide at type 2 diabetes diagnosis is an independent risk factor for total and cancer mortality" Open
View article: Review for "Fasting C‐peptide at type 2 diabetes diagnosis is an independent risk factor for total and cancer mortality"
Review for "Fasting C‐peptide at type 2 diabetes diagnosis is an independent risk factor for total and cancer mortality" Open
View article: Blood Glucose Level Forecasting on Type-1-Diabetes Subjects during Physical Activity: A Comparative Analysis of Different Learning Techniques
Blood Glucose Level Forecasting on Type-1-Diabetes Subjects during Physical Activity: A Comparative Analysis of Different Learning Techniques Open
Background: Type 1 Diabetes Mellitus (T1DM) is a widespread chronic disease in industrialized countries. Preventing blood glucose levels from exceeding the euglycaemic range would reduce the incidence of diabetes-related complications and …
View article: Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease
Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease Open
In type 2 diabetes, anti-thrombotic management is challenging, and current anti-platelet agents have demonstrated reduced efficacy. Old and new anti-diabetic drugs exhibited—besides lowering blood glucose levels—direct and indirect effects…
View article: Effects of the <scp>COVID</scp> ‐19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study
Effects of the <span>COVID</span> ‐19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study Open
Aim To assess the effect of the coronavirus disease 2019 (COVID‐19) lockdown on glycaemic control in subjects with type 2 diabetes (T2D). Materials and Methods In this observational, multicentre, retrospective study conducted in the Lazio …
View article: The Vicious Circle of Left Ventricular Dysfunction and Diabetes: From Pathophysiology to Emerging Treatments
The Vicious Circle of Left Ventricular Dysfunction and Diabetes: From Pathophysiology to Emerging Treatments Open
Context Diabetes and heart failure (HF) are 2 deadly and strictly related epidemic disorders. The aim of this review is to present an updated discussion of the epidemiology, pathophysiology, clinical presentation and treatment options for …
View article: Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy
Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy Open
The coronavirus disease 2019 (COVID-19) outbreak forced Italy to begin lockdown on 9 March 2020. This suddenly changed the daily routine of people with diabetes, increasing sedentary behavior, changing eating patterns, and increasing their…
View article: Correction to: “H” for Heterogeneity in the Algorithm for Type 2 Diabetes Management
Correction to: “H” for Heterogeneity in the Algorithm for Type 2 Diabetes Management Open
View article: Hypoglycaemia and its management in primary care setting
Hypoglycaemia and its management in primary care setting Open
Hypoglycaemia is common in patients with type 1 diabetes and type 2 diabetes and constitutes a major limiting factor in achieving glycaemic control among people with diabetes. While hypoglycaemia is defined as a blood glucose level under 7…
View article: Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management
Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management Open
Latent autoimmune diabetes in adults (LADA) is a heterogeneous disease characterized by a less intensive autoimmune process and a broad clinical phenotype compared to classical type 1 diabetes mellitus (T1DM), sharing features with both ty…
View article: Latent Autoimmune Diabetes in Adults: Current Status and New Horizons
Latent Autoimmune Diabetes in Adults: Current Status and New Horizons Open
Autoimmune diabetes is a heterogeneous disease which can arise at any age. Subjects with adult-onset autoimmune diabetes who do not necessitate insulin-therapy for at least 6 months after diagnosis are demarcated as having latent autoimmun…